Troy Cox is CEO at Foundation Medicine, Inc. (FMI). They have made 7 open-market trades across 3 companies since 2018, most recently 2026-07-28.
CIK 0001696923
2 open-market purchases totalling $497K since 2020, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FMI | 206,847 | $28.3M |
| SOPH | 328,743 | $2.2M |
| LAB | 475,702 | $302K |
| SLGC | 106,930 | $225K |
| ZYME | 7,500 | $188K |
| MPLT | 15,620 | $120K |
| SLGCW | 25,000 | — |
| Total | $31.4M |
Shares reported on the most recent Form 4, priced at the 2026-07-28 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MPLT | BUY | 2026-07-28 | 2026-07-28 | $9.52 | $149K | -5.6% | -3.0% | — |
| ZYME | BUY | 2020-01-27 | 2020-01-28 | $46.50 | $349K | +2.7% | -10.9% | -14.0% |
| FMI | SELL | 2018-07-02 | 2018-07-05 | $136.66 | $383K | +0.1% | N/A | N/A |
| FMI | SELL | 2018-05-16 | 2018-05-17 | $77.10 | $333K | +23.7% | +32.8% | N/A |
| FMI | SELL | 2018-05-07 | 2018-05-09 | $70.01 | $989K | +17.1% | +31.6% | N/A |
| FMI | SELL | 2018-02-15 | 2018-02-20 | $67.22 | $1.2M | +6.5% | +6.2% | +12.8% |
| FMI | SELL | 2018-02-07 | 2018-02-09 | $70.13 | $3.7M | +12.8% | +26.3% | +13.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.